tiprankstipranks
Metacrine (MTCR)
OTHER OTC:MTCR
US Market
Holding MTCR?
Track your performance easily

Metacrine (MTCR) Income Statement

0 Followers

Metacrine Income Statement

Last quarter (Q ), Metacrine's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Metacrine's net income was $-5.52M. See Metacrine’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18
Total Revenue
--$ 0.00$ 0.00$ 1.45M
Cost of Revenue
-----
Gross Profit
-----
Operating Expense
$ 25.81M$ 61.08M$ 36.69M$ 30.00M$ 28.18M
Operating Income
$ -36.13M$ -61.08M$ -36.69M$ -30.00M$ -26.73M
Net Non Operating Interest Income Expense
$ -1.60M$ -1.10M$ -518.00K$ 1.07M$ 934.00K
Other Income Expense
$ -386.00K$ 28.00K$ -96.00K-$ -26.00K
Pretax Income
$ -38.19M$ -62.21M$ -37.30M$ -28.93M$ -25.82M
Tax Provision
-$ -4.34M---
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -38.19M$ -62.21M$ -37.30M$ -28.93M$ -25.82M
Basic EPS
$ -0.91-$ -3.97$ -1.52$ -1.35
Diluted EPS
$ -0.91$ -2.29$ -3.97$ -1.52$ -1.35
Basic Average Shares
$ 156.98M$ 27.19M$ 9.40M$ 19.06M$ 19.06M
Diluted Average Shares
$ 156.98M$ 27.19M$ 9.40M$ 19.06M$ 19.06M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 25.81M$ 61.08M$ 36.69M$ 30.00M$ 28.18M
Net Income From Continuing And Discontinued Operation
$ -38.19M$ -62.21M$ -37.30M$ -28.93M$ -25.82M
Normalized Income
$ -31.77M-$ -37.30M$ -28.93M$ -25.82M
Interest Expense
$ 1.38M-$ 1.01M$ 347.00K$ 0.00
EBIT
$ -36.48M$ -61.11M$ -36.29M$ -28.59M$ -25.82M
EBITDA
$ -35.99M$ -59.79M$ -35.36M$ -27.76M$ -24.99M
Currency in USD

Metacrine Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis